Osman Guvenc, Serdar Beken, Saygin Abali, Neslihan Yildirim Saral, Gizem Yalcin, Eda Albayrak, Burcu Bulum, Ozlem Demirelce, Serdar Basgoze, Ender Odemis, Ersin Erek, Mustafa Serteser, Ayse Korkmaz Toygar
Cardiology in the young 2023 MarCyanotic CHD is a life-threatening condition that presents with low oxygen saturation in the newborn period. Hypoxemia might cause alterations in the metabolic pathways. In the present study, we aimed to evaluate the early postnatal amino acid and carnitine/acylcarnitine profiles of newborn infants with cyanotic CHD. A single centre case-control study was conducted. Twenty-seven patients with cyanotic CHD and 54 healthy newborn controls were enrolled. As part of the neonatal screening programme, results of amino acid and carnitine/acylcarnitine were recorded and compared between groups. Twenty-seven neonates with cyanotic CHD and 54 healthy newborns as controls were enrolled in the study. Cyanotic CHD neonates had higher levels of alanine, phenylalanine, leucine/isoleucine, citrulline, ornithine, C5, C5-OH; but lower levels of C3, C10, C12, C14, C14:1, C16, C16.1, C18, C5-DC, C6-DC, C16-OH, C16:1-OH when compared with the healthy controls. This study showed that there are differences between patients with cyanotic CHD and healthy controls in terms of postnatal amino acid and carnitine/acylcarnitine profiles.
Osman Guvenc, Serdar Beken, Saygin Abali, Neslihan Yildirim Saral, Gizem Yalcin, Eda Albayrak, Burcu Bulum, Ozlem Demirelce, Serdar Basgoze, Ender Odemis, Ersin Erek, Mustafa Serteser, Ayse Korkmaz Toygar. Early postnatal metabolic profile in neonates with critical CHDs. Cardiology in the young. 2023 Mar;33(3):349-353
PMID: 36193679
View Full Text